Live feed
Filing
SC 13D
SC 13D0001513162-21-000157·FiveT Investment Management Ltd
Schedule 13D ownership disclosure
INHIBIKASE THERAPEUTICS INC
Security class unavailable · CUSIP: 45719W106
Event date: 2021-12-14
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,250,000
- Percent of class
- 4.9700%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001513162-21-000157
- Form type
- SC 13D
- Filer
- FiveT Investment Management Ltd
- CIK
- CIK 1846823
- Filed
- Dec 15, 2021
- Reporting period
- Dec 14, 2021
- Description
- Schedule 13D beneficial ownership